Cardiovascular disease is the most common cause of death in the world. In severe cases,
replacement or revascularization using vascular grafts are the treatment options. While …

Recent decades have seen a plethora of regenerating new tissues in order to treat a
multitude of cardiovascular diseases. Autografts, xenografts and bioengineered extracellular …

Decellularization of blood vessels is a promising approach to generate native biomaterials
for replacement of diseased vessels. The decellularization process affects the mechanical …

Due to the prevalence of cardiovascular disease in the United States, small-caliber vascular
grafts for coronary bypass surgery continue to be in high demand. Human umbilical arteries …

Background: The decellularized scaffold is a promising material for producing tissue-
engineered vascular grafts (TEVGs) because of its complex, native-like three-dimensional …

In the early years of tissue engineering, scientists focused on the generation of healthy-like
tissues and organs to replace diseased tissue areas with the aim of filling the gap between …

Cardiovascular diseases remain a leading cause of mortality globally, with atherosclerosis
representing a significant pathological means, often leading to myocardial infarction …

Background To determine the effectiveness of ethanol (EtOH) washing on porcine
pulmonary artery (PA) wall decellularization using sodium dodecyl sulfate (SDS), we …

Vascular diseases are the largest cause of death globally and impose a major global burden
on healthcare. The gold standard for treating vascular diseases is the transplantation of …

To successfully engineer large-sized tissues, establishing vascular structures is essential for
providing oxygen, nutrients, growth factors and cells to prevent necrosis at the core of the …